BGB-3245
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BGB-3245, covering 2025-02-17 to 2025-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors [Phase 1]